Sydney Kruger is a seasoned clinical development leader with over a decade of experience driving clinical operations for biopharmaceutical companies. As Vice President of Clinical Development Operations at Rein Therapeutics, Inc., Sydney leads the clinical operations group in executing clinical development plans. With a strong background in clinical trial management, operational strategy, and vendor oversight, Sydney ensures that clinical trials are delivered on-time, within budget, and in compliance with regulatory standards. Sydney plays a crucial role in advising on clinical development progress and continuously strives for innovative solutions to address operational challenges.
Sydney's career has been marked by leadership roles in clinical operations, in both the biopharmaceutical and clinical research organization realms. In these roles she was responsible for driving clinical trial execution, collaborating with cross-functional teams, and supporting senior leadership in clinical decision-making as well as overseeing clinical trial activities and providing strategic input on regulatory inspections and trial design.
Sydney holds a Master of Science in Leadership, a Graduate Certificate in Health Management, and a Bachelor of Science in Health Science, all from Northeastern University. She is deeply committed to developing the next generation of clinical operations leaders and fostering a collaborative and high-performance environment.